The picosecond handpiece that masters the art of balance.
The expanding portfolio of PicoWay system applicators now includes the 730 nm wavelength handpiece, FDA-cleared for treatment of benign pigmented lesions and blue and green tattoo removal.1 The hallmark of the 730 nm handpiece is its precise balance between an optimized wavelength (730 nm) and the shortest pulse durationa (a remarkable 250 ps), allowing it to efficiently target pigment while minimizing risk of hypo- or hyperpigmentation and impact on surrounding tissues.2,3
- 730 nm Optimized Wavelength
- The 730 nm has highly targeted melanin absorption, with 14% more melanin absorption than the competitive 755 nm picosecond wavelength4
- 250 ps Shortest Pulse Durationa
- The 730 nm applicator has the shortest pulse durationa to reduce thermal impact and boost photoacoustic effect.5
- It enjoys a 66% shorter pulse duration (250 ps) compared to the competitor’s 750 ps pulse duration for their 755 nm wavelength.6
- The 730 nm wavelength has less hemoglobin absorption than other wavelengths with a melanosome to blood absorption ratio of <50:1, allowing more targeting of browns and less unintended targeting of reds.4
a. Based on available 510(k) summaries as of December 2019.
1. PicoWay 510(k) clearance (K191685), Sept. 2019.
2. Artzi O et al. Lasers Med Sci. 2018;33(4):693-697.
3. Serup J, Bäumler W (eds): Diagnosis and Therapy of Tattoo Complications. With Atlas of Illustrative Cases. Curr Probl Dermatol. Basel, Karger, 2017, vol 52, pp 113 -123 (DOI: 10.1159/000450812).
4. Candela data on file 2020.
5. Kung KY, Shek SY, Yeung CK, Chan HH. Lasers Surg Med. 2019 Jan;51(1):14- 22. doi: 10.1002/lsm.23028. Epub 2018 Oct 25.
6. Based on published manufacturer specifications as of December 2019.